These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 26699289)
1. Practical considerations in the selection of seed strength for prostate implants. Elliott SL; Beaufort CL; Millar JL J Appl Clin Med Phys; 2015 Sep; 16(5):53-61. PubMed ID: 26699289 [TBL] [Abstract][Full Text] [Related]
2. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose. Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195 [TBL] [Abstract][Full Text] [Related]
3. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants. Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782 [TBL] [Abstract][Full Text] [Related]
4. Loose versus stranded seeds in permanent prostate brachytherapy: dosimetric comparison of intraoperative plans. Major T; Agoston P; Fröhlich G; Baricza K; Szabo Z; Jorgo K; Herein A; Polgar C Phys Med; 2014 Dec; 30(8):909-13. PubMed ID: 25175151 [TBL] [Abstract][Full Text] [Related]
5. [Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy]. Herein A; Ágoston P; Szabó Z; Jorgo K; Markgruber B; Pesznyák C; Polgár C; Major T Magy Onkol; 2015 Jun; 59(2):148-53. PubMed ID: 26035163 [TBL] [Abstract][Full Text] [Related]
6. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy. Stone NN; Hong S; Lo YC; Howard V; Stock RG Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159 [TBL] [Abstract][Full Text] [Related]
7. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry. Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092 [TBL] [Abstract][Full Text] [Related]
8. Intraoperative dynamic dose optimization in permanent prostate implants. Lee EK; Zaider M Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):854-61. PubMed ID: 12788195 [TBL] [Abstract][Full Text] [Related]
9. A method for confirming a third-party assay of I-125 seeds used for prostate implants. Muryn JS; Wilkinson DA J Appl Clin Med Phys; 2017 Jan; 18(1):53-58. PubMed ID: 28291924 [TBL] [Abstract][Full Text] [Related]
10. The effect of the radial function on I-125 seeds used for permanent prostate implantation. Pickett B; Pouliot J Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917 [TBL] [Abstract][Full Text] [Related]
11. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs. Beaulieu L; Archambault L; Aubin S; Oral E; Taschereau R; Pouliot J Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1298-308. PubMed ID: 15001275 [TBL] [Abstract][Full Text] [Related]
12. Seed displacements after permanent brachytherapy for prostate cancer in dependence on the prostate level. Pinkawa M; Gagel B; Asadpour B; Piroth MD; Klotz J; Borchers H; Jakse G; Eble MJ Strahlenther Onkol; 2008 Oct; 184(10):520-5. PubMed ID: 19016041 [TBL] [Abstract][Full Text] [Related]
13. Robustness to source displacement in dual air kerma strength planning for focal low-dose-rate brachytherapy of prostate cancer. Mahdavi SS; Spadinger IT; Chng NT; Morris WJ Brachytherapy; 2016; 15(5):642-9. PubMed ID: 27263060 [TBL] [Abstract][Full Text] [Related]
14. Prostate brachytherapy postimplant dosimetry: a comparison of suture-embedded and loose seed implants. Spadinger I; Hilts M; Keyes M; Smith C; Sidhu S; Morris WJ Brachytherapy; 2006; 5(3):165-73. PubMed ID: 16864068 [TBL] [Abstract][Full Text] [Related]
15. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants. Chibani O; Williamson JF; Todor D Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786 [TBL] [Abstract][Full Text] [Related]
17. Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy. Collins Fekete CA; Plamondon M; Martin AG; Vigneault É; Verhaegen F; Beaulieu L Med Phys; 2014 Oct; 41(10):101704. PubMed ID: 25281943 [TBL] [Abstract][Full Text] [Related]
18. Inverse automated treatment planning with and without individual optimization in interstitial permanent prostate brachytherapy with high- and low-activity 125I. Pinkawa M; Maurer U; Mulhern A; Gagel B; Block T; Borchers H; Grieger J; Henkel T; Eble M Strahlenther Onkol; 2003 Jun; 179(6):417-22. PubMed ID: 12789469 [TBL] [Abstract][Full Text] [Related]
19. Treatment technique evolution and dosimetry trends over seven years of low dose rate prostate brachytherapy at an Australian institution. Rutten TP; Lawson JM; Marcu LG Phys Med; 2013 Nov; 29(6):662-9. PubMed ID: 22975428 [TBL] [Abstract][Full Text] [Related]
20. Influence of source batch S dispersion on dosimetry for prostate cancer treatment with permanent implants. Nuñez-Cumplido E; Perez-Calatayud J; Casares-Magaz O; Hernandez-Armas J Med Phys; 2015 Aug; 42(8):4933-40. PubMed ID: 26233219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]